SCHEMBL4940255

SCHEMBL4940255

COC(=O)c1ccc(-c2c(C)cccc2C)o1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 2/20 0.60
HTT P42858 3/20 0.50
ALDH1A1 P00352 3/20 0.50
LMNA P02545 2/20 0.50
RAB9A P51151 2/20 0.50
MAPT P10636 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALOX12 P18054 1/20 0.49
SETD7 Q8WTS6 1/20 0.49
MEN1 O00255 2/20 0.47
CYP1A2 P05177 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP2C19 P33261 1/20 0.47
S1PR4 O95977 2/20 0.47
SRC P12931 1/20 0.46
KDM4E B2RXH2 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21981938 0.83 HTT (0.67) HTTALDH1A1LMNARAB9AMAPT
SCHEMBL4937154 0.82 SLC9A1 (0.62) SLC9A1HTTALDH1A1LMNARAB9A
SCHEMBL4946365 0.81 ALDH1A1 (0.61) SLC9A1HTTALDH1A1LMNARAB9A
SCHEMBL4942885 0.81 ALDH1A1 (0.50) SLC9A1HTTALDH1A1LMNARAB9A
SCHEMBL4949369 0.81 PDE4B (0.52) HTTALDH1A1LMNARAB9AMAPT
SCHEMBL69791 0.77 HTT (0.69) HTTALDH1A1LMNARAB9AMAPT
SCHEMBL4946641 0.76 SLC9A1 (0.57) SLC9A1HTTALDH1A1LMNAMAPT
SCHEMBL4946645 0.76 SLC9A1 (1.00) SLC9A1
SCHEMBL4943045 0.76 SLC9A1 (0.62) SLC9A1HTTALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4948212 0.75 SETD7 (0.46) HTTALDH1A1LMNARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351843-B2 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-04-01 US disclosed
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them SLC9A1, NHERF1, SLC5A1 SLC9A1 1/4885HTT 405/4885ALDH1A1 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.